{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:08:01Z","timestamp":1789614481301,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Supraventricular tachycardia (SVT) is one of the most common non-benign arrhythmias in neonates, potentially leading to cardiac decompensation. This study investigated the early risk factors of acute heart failure (AHF) secondary to SVT in neonates, and explored their value in guiding the selection of effective anti-arrhythmic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 43 newborns diagnosed with and treated for SVT between January 2017 and December 2022 were analyzed. According to the presence of AHF after restoring sinus rhythm in newborns with SVT, they were divided into SVT with AHF group and SVT without AHF group. Clinical data and anti-arrhythmic therapies were analyzed. Risk factors of AHF secondary to SVT in neonates were determined using logistic regression. The cut-off value for predictors of AHF secondary to SVT and demanding of a second-line anti-arrhythmic treatment was determined through receiver operating characteristic (ROC) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Time to initial control of tachycardia\u2009&gt;\u200924\u00a0h, hyperkalemia, anemia, and plasma B-type natriuretic peptide (BNP) were identified as risk factors of AHF secondary to SVT in neonates. BNP exhibited AUC of 0.80 in predicting AHF, and BNP\u2009&gt;\u20092460.5pg\/ml (OR 2.28, 95% CI 1.27\u2009~\u200945.39,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03) was an independent predictor, yielding sensitivity of 70.6% and specificity of 84.6%. Neonates with BNP\u2009&gt;\u20092460.5pg\/ml (37.5% versus 7.4%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04) had a higher demand for a second line anti-arrhythmic treatment to terminate SVT, with sensitivity and specificity for BNP in predicting at 75.0%, 71.4%, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>BNP could be used to predict an incident of AHF secondary to SVT and a demand of second-line anti-arrhythmic treatment to promptly terminate SVT and prevent decompensation in neonates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03646-5","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T05:02:01Z","timestamp":1702011721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rediscover the predictive capacity of B-type natriuretic peptide applied to neonatal supraventricular tachycardia"],"prefix":"10.1186","volume":"23","author":[{"given":"Yaheng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"issue":"6","key":"3646_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ipej.2019.09.004","volume":"19","author":"C Srinivasan","year":"2019","unstructured":"Srinivasan C, Balaji S. Neonatal supraventricular tachycardia. Indian Pacing Electrophysiol J. 2019;19(6):222\u201331.","journal-title":"Indian Pacing Electrophysiol J"},{"issue":"1","key":"3646_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1058-9813(00)00033-3","volume":"11","author":"JP Moak","year":"2000","unstructured":"Moak JP. Supraventricular tachycardia in the neonate and infant. Prog Pediatr Cardiol. 2000;11(1):25\u201338.","journal-title":"Prog Pediatr Cardiol"},{"issue":"1","key":"3646_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.diff.2012.04.006","volume":"84","author":"MR Jongbloed","year":"2012","unstructured":"Jongbloed MR, Vicente Steijn R, Hahurij ND, et al. Normal and abnormal development of the cardiac conduction system; implications for conduction and rhythm disorders in the child and adult. Differentiation. 2012;84(1):131\u201348.","journal-title":"Differentiation"},{"issue":"1","key":"3646_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.clp.2015.11.007","volume":"43","author":"E Jaeggi","year":"2016","unstructured":"Jaeggi E, \u00d6hman A. Fetal and neonatal arrhythmias. Clin Perinatol. 2016;43(1):99\u2013112.","journal-title":"Clin Perinatol"},{"issue":"7","key":"3646_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00246-017-1662-1","volume":"38","author":"KA Hinkle","year":"2017","unstructured":"Hinkle KA, Peyvandi S, Stiver C, et al. Postnatal outcomes of fetal supraventricular tachycardia: a Multicenter Study. Pediatr Cardiol. 2017;38(7):1317\u201323.","journal-title":"Pediatr Cardiol"},{"issue":"18 Suppl 2","key":"3646_CR6","first-page":"526","volume":"132","author":"AR de Caen","year":"2015","unstructured":"de Caen AR, Berg MD, Chameides L, et al. Part 12: Pediatric Advanced Life support: 2015 American Heart Association guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015;132(18 Suppl 2):526\u2013S542.","journal-title":"Circulation"},{"issue":"1","key":"3646_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12872-020-01843-0","volume":"21","author":"G Capponi","year":"2021","unstructured":"Capponi G, Belli G, Giovannini M, et al. Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre. BMC Cardiovasc Disord. 2021;21(1):137.","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"3646_CR8","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00431-021-04159-z","volume":"180","author":"L K\u00f6rnyei","year":"2021","unstructured":"K\u00f6rnyei L, Szab\u00f3 A, R\u00f3th G, Ferenci T, Kardos A. Supraventricular tachycardias in neonates and infants: factors associated with fatal or near-fatal outcome. Eur J Pediatr. 2021;180(8):2669\u201376. https:\/\/doi.org\/10.1007\/s00431-021-04159-z.","journal-title":"Eur J Pediatr"},{"issue":"8","key":"3646_CR9","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00246-012-0306-8","volume":"33","author":"RD Ross","year":"2012","unstructured":"Ross RD. The Ross classification for Heart Failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol. 2012;33(8):1295\u2013300.","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"3646_CR10","doi-asserted-by":"publisher","first-page":"e1238","DOI":"10.1542\/peds.2011-3134","volume":"129","author":"HL Ersdal","year":"2012","unstructured":"Ersdal HL, Mduma E, Svensen E, Perlman J. Birth Asphyxia: a major cause of early neonatal mortality in a Tanzanian rural hospital. Pediatrics. 2012;129(5):e1238\u201343.","journal-title":"Pediatrics"},{"issue":"1","key":"3646_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.siny.2015.12.001","volume":"21","author":"R Colombatti","year":"2016","unstructured":"Colombatti R, Sainati L, Trevisanuto D. Anemia and transfusion in the neonate. Semin Fetal Neonatal Med. 2016;21(1):2\u20139.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"3646_CR12","first-page":"CD008680","volume":"13","author":"R Martis","year":"2017","unstructured":"Martis R, Emilia O, Nurdiati DS, Brown J. Intermittent auscultation (IA) of fetal heart rate in labour for fetal well-being. Cochrane Database Syst Rev. 2017;13(2):CD008680.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"3646_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/anec.12246","volume":"20","author":"C Butt\u00e0","year":"2015","unstructured":"Butt\u00e0 C, Tuttolomondo A, Giarrusso L, Pinto A. Electrocardiographic diagnosis of atrial tachycardia: classification, P-wave morphology, and differential diagnosis with other supraventricular tachycardias. Ann Noninvasive Electrocardiol. 2015;20(4):314\u201327.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"11","key":"3646_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3345\/kjp.2017.60.11.344","volume":"60","author":"JE Ban","year":"2017","unstructured":"Ban JE. Neonatal arrhythmias: diagnosis, treatment, and clinical outcome. Korean J Pediatr. 2017;60(11):344\u201352.","journal-title":"Korean J Pediatr"},{"issue":"9","key":"3646_CR15","first-page":"793","volume":"92","author":"MR Helton","year":"2015","unstructured":"Helton MR. Diagnosis and management of common types of supraventricular tachycardia. Am Fam Physician. 2015;92(9):793\u2013800.","journal-title":"Am Fam Physician"},{"issue":"10","key":"3646_CR16","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.hrthm.2016.06.006","volume":"13","author":"MH Wu","year":"2016","unstructured":"Wu MH, Chen HC, Kao FY, Huang SK. Postnatal cumulative incidence of supraventricular tachycardia in a general pediatric population: a national birth cohort database study. Heart Rhythm. 2016;13(10):2070\u20135.","journal-title":"Heart Rhythm"},{"issue":"6","key":"3646_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0022-3476(81)80578-1","volume":"98","author":"A Garson Jr","year":"1981","unstructured":"Garson A Jr, Gillette PC, McNamara DG. Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr. 1981;98(6):875\u201382.","journal-title":"J Pediatr"},{"issue":"6","key":"3646_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.24953\/turkjped.2020.06.019","volume":"62","author":"\u0130 Fidanc\u0131","year":"2020","unstructured":"Fidanc\u0131 \u0130, G\u00fclery\u00fcz OD, Yenice \u00d6D. Successful intraosseous adenosine administration in a newborn infant with supraventricular tachycardia. Turk J Pediatr. 2020;62(6):1064\u20138.","journal-title":"Turk J Pediatr"},{"issue":"2","key":"3646_CR19","first-page":"167","volume":"9","author":"AS NADAS","year":"1952","unstructured":"NADAS AS, DAESCHNER CW, BLUMENTHAL ROTHA. Paroxysmal tachycardia in infants and children; study of 41 cases. Pediatrics. 1952;9(2):167\u201381.","journal-title":"Pediatrics"},{"issue":"3","key":"3646_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00246-020-02515-8","volume":"42","author":"R Przybylski","year":"2021","unstructured":"Przybylski R, Michelson KA, Neuman MI, Porter JJ, Alexander ME, Lyons TW. Care of children with supraventricular tachycardia in the Emergency Department. Pediatr Cardiol. 2021;42(3):569\u201377.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"3646_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/14767058.2016.1275545","volume":"31","author":"PP Bassareo","year":"2018","unstructured":"Bassareo PP, Fanos V, Pala M, et al. Supraventricular tachycardia during the first year of life: is subclinical inflammation the trigger? J Matern Fetal Neonatal Med. 2018;31(1):53\u20138.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"3646_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10741-014-9422-2","volume":"19","author":"M Cantinotti","year":"2014","unstructured":"Cantinotti M, Law Y, Vittorini S, et al. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with Heart Failure due to congenital cardiac Disease: an update. Heart Fail Rev. 2014;19(6):727\u201342.","journal-title":"Heart Fail Rev"},{"issue":"5","key":"3646_CR23","first-page":"483","volume":"115","author":"GL Salas","year":"2017","unstructured":"Salas GL, Jozefkowicz M, Goldsmit GS, et al. B-type natriuretic peptide: usefulness in the management of critically-ill neonates. P\u00e9ptido natriur\u00e9tico tipo B: utilidad en El manejo de reci\u00e9n nacidos cr\u00edticamente enfermos. Arch Argent Pediatr. 2017;115(5):483\u20139.","journal-title":"Arch Argent Pediatr"},{"issue":"7","key":"3646_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/j.1540-8159.2011.03073.x","volume":"34","author":"JC Salerno","year":"2011","unstructured":"Salerno JC, Garrison MM, Larison C, Seslar SP. Case fatality in children with supraventricular tachycardia in the United States. Pacing Clin Electrophysiol. 2011;34(7):832\u20136.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"3646_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/jce.14406","volume":"31","author":"ET O\u2019Leary","year":"2020","unstructured":"O\u2019Leary ET, Alexander ME, Bezzerides VJ, et al. Low mortality in fetal supraventricular tachycardia: outcomes in a 30-year single-institution experience. J Cardiovasc Electrophysiol. 2020;31(5):1105\u201313.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8","key":"3646_CR26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1651-2227.2008.00823.x","volume":"97","author":"T Gilljam","year":"2008","unstructured":"Gilljam T, Jaeggi E, Gow RM. Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta Paediatr. 2008;97(8):1035\u20139.","journal-title":"Acta Paediatr"},{"issue":"4","key":"3646_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0036-1583543","volume":"5","author":"M Cantinotti","year":"2016","unstructured":"Cantinotti M. B-Type Cardiac natriuretic peptides in the neonatal and Pediatric Intensive Care Units. J Pediatr Intensive Care. 2016;5(4):189\u201397.","journal-title":"J Pediatr Intensive Care"},{"issue":"1","key":"3646_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1055\/s-0037-1603760","volume":"7","author":"S Reeves","year":"2018","unstructured":"Reeves S, Womack C, Lutherer LO, Todd C, Pinkney K, Kasemsri T. What is high Enough? Elevated NT-pro-BNP in decompensated paroxysmal supraventricular tachycardia. J Pediatr Intensive Care. 2018;7(1):49\u201353.","journal-title":"J Pediatr Intensive Care"},{"issue":"7","key":"3646_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.tcm.2016.03.011","volume":"26","author":"OJ Ziff","year":"2016","unstructured":"Ziff OJ, Kotecha D. Digoxin: the good and the bad. Trends Cardiovasc Med. 2016;26(7):585\u201395.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"3646_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/11208210-000000000-00000","volume":"72","author":"KP Garnock-Jones","year":"2012","unstructured":"Garnock-Jones KP. Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and Hypertension. Drugs. 2012;72(1):109\u201332.","journal-title":"Drugs"},{"issue":"3","key":"3646_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3109\/14767058.2010.509915","volume":"24","author":"MC Tavera","year":"2011","unstructured":"Tavera MC, Bassareo PP, Neroni P, et al. Supraventricular tachycardia in neonates: antiarrhythmic drug choice dilemma. J Matern Fetal Neonatal Med. 2011;24(3):541\u20134.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"3646_CR32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s00246-016-1375-x","volume":"37","author":"K Guerrier","year":"2016","unstructured":"Guerrier K, Shamszad P, Czosek RJ, Spar DS, Knilans TK, Anderson JB. Variation in Antiarrhythmic Management of Infants Hospitalized with supraventricular tachycardia: a multi-institutional analysis. Pediatr Cardiol. 2016;37(5):946\u201352.","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"3646_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/ped.13445","volume":"60","author":"G Tunca Sahin","year":"2018","unstructured":"Tunca Sahin G, Ozturk E, Kasar T, Guzeltas A, Ergul Y. Sustained tachyarrhythmia in children younger than 1 year of age: six year single-center experience. Pediatr Int. 2018;60(2):115\u201321.","journal-title":"Pediatr Int"},{"issue":"7","key":"3646_CR34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/pace.13964","volume":"43","author":"M Bjelo\u0161evi\u010d","year":"2020","unstructured":"Bjelo\u0161evi\u010d M, Ill\u00edkov\u00e1 V, Tomko J, Olejn\u00edk P, Chalupka M, Hatala R. Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: a 10-year population-based study. Pacing Clin Electrophysiol. 2020;43(7):680\u20136.","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03646-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T05:03:43Z","timestamp":1702011823000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03646-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3646"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03646-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3104256\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"assertion":[{"value":"24 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Medical Ethics Committee of the Chengdu Women\u2019s and Children\u2019s Central Hospital, Chengdu, China, and was approved with a waiver of informed consent due to research not involving greater than minimal risk and the retrospective nature of the study. This study was performed in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"603"}}